Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 30.53% vs 32.11% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 33.49% vs 9.13% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 5.51% vs -2.52% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 56.10% vs 17.75% in Mar 2025
Compare Profit and Loss Results of Saroja Pharma In
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
70.00
10.00
60.00
600.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
70.00
10.00
60.00
600.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
64.00
4.00
60.00
1,500.00%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1.00
1.00
0.00
0.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
66.00
10.00
56.00
560.00%
Operating Profit (PBDIT) excl Other Income
3.00
0.00
3.00
0%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
3.00
0.00
3.00
0%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
2.00
0.00
2.00
0%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
2.00
0.00
2.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2.00
0.00
2.00
0%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
1.00
0.00
1.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
4.00
2.00
2.00
100.00%
Profit Available for appropriations
5.00
2.00
3.00
150.00%
Appropriations
5.00
2.00
3.00
150.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
4.02
0.003
4.02
133,900.00%
Profit And Loss - Net Sales
Net Sales 70.13 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 30.53% vs 32.11% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.72 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 33.49% vs 9.13% in Mar 2025
Profit And Loss - Interest
Interest 1.49 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 5.51% vs -2.52% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 1.61 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 56.10% vs 17.75% in Mar 2025
Footer loading
